期刊
INTERNATIONAL IMMUNOPHARMACOLOGY
卷 105, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.intimp.2022.108571
关键词
Cladribine; Astrocytes; Microglia; Deoxycytidine kinase; 5'-nucleotidases
Cladribine (2CdA) is a synthetic drug that reduces immune cells related to multiple sclerosis. It has been found to have effects on microglial cells, including inhibiting proliferation, inducing apoptosis, and reducing cytokine production. However, it has limited effects on astrocytes.
Cladribine (2CdA) is a synthetic chlorinated purine nucleoside analogue which acts as a pro-drug requiring intracellular phosphorylation to be activated. It is biologically active in selected cell types, which results in a reduction of circulating T and B lymphocytes implicated in multiple sclerosis (MS) pathogenesis. In addition, 2CdA shows good central nervous system (CNS) penetration and can therefore exert its action on microglia and astrocytes. Therefore, we studied the effects of 2CdA on microglial cells and astrocytes, both emerging as potential targets for MS therapy. Other than its effects on the peripheral immune system, 2CdA induced the apoptosis of microglial cells, inhibited their proliferation and reduced the production of cytokines, particularly pro-inflammatory cytokines IL-1 beta, IL-6 and TNF-alpha. These represent additional mechanisms of 2CdA that may contribute to limiting inflammatory pathways. By contrast, astrocytes showed resistance to the action of 2CdA, which may be explained by differences in its intracellular phosphorylation. Insights into the mechanism of action of and resistance to 2CdA in CNS-resident cells may prove crucial for its optimal use.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据